GlassScriptPhysician profile
Moiz Hassan
NPI 1427511732
$17,792.19
in general payments reported to CMS, 2019-2025
21 companies · $4,876 in 2025
The $4,876 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.14 · 2021: $268 · 2022: $1,114 · 2023: $3,063 · 2024: $8,458 · 2025: $4,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Consulting Fee: $6,287 · Food and Beverage: $1,206 · Travel and Lodging: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Consulting Fee | $6,286.55 |
| Food and Beverage | $1,205.65 |
| Travel and Lodging | $904.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pathway Medical Partners, LLC | $10,000.00 | 2023-2024 | |
| Flower Orthopedics Coporation | $4,357.72 | 2025 | |
| Stryker Corporation | $1,140.17 | 2022-2025 | Augment Injectable, 7 X 23mm Citrelock Implant, Citrefix |
| Wardlow Enterprises | $577.09 | 2022-2023 | |
| Arthrex, INC. | $462.48 | 2023 | |
| Smith+Nephew, INC. | $362.70 | 2021-2025 | Grafix Pl, Stravix Mesh, Stravix |
| Depuy Synthes Sales INC. | $149.88 | 2022 | |
| Treace Medical Concepts, INC. | $135.06 | 2023-2025 | |
| Horizon Therapeutics Plc | $126.68 | 2021 | |
| Djo, LLC | $100.00 | 2022 | |
| Linvatec Corporation | $82.15 | 2024-2025 | Biobrace 23mm |
| Averitas Pharma INC. | $72.11 | 2024-2025 | Qutenza |
| Ucb, INC. | $44.38 | 2025 | Bimzelx |
| Acera Surgical, INC. | $37.04 | 2024 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $30.83 | 2024 | Iovera, Zilretta, Exparel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $30.51 | 2025 | Snap, Activ.A.C., Promogran Prisma |
| Hartmann USA, INC. | $23.01 | 2025 | Zetuvit Plus 10x10 P10 |
| 180 Medical, INC. | $17.77 | 2025 | Gentlecath |
| Mimedx Group, INC. | $17.12 | 2025 | |
| Merck Sharp & Dohme LLC | $13.14 | 2019 | |
| Next Science LLC | $12.35 | 2024 | Surgx, Blastx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moiz Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.